These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 4474796)

  • 1. Apomorphine derivatives and dopaminergic activity.
    Lal S; Sourkes TL
    Adv Neurol; 1974; 5():307-8. PubMed ID: 4474796
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of nigral dopaminergic firing by N-n-propyl-norapomorphine: behavioural and biochemical correlates.
    Mereu G; Argiolas A; Melis MR; Gessa GL
    Ann Ist Super Sanita; 1982; 18(1):57-61. PubMed ID: 6892092
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III.
    Jasztold-Howorko R; Machoń Z; Wilimowski M; Wojewódzki W; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Duś E; Dziewiszek W; Rutkowska M
    Pol J Pharmacol; 1995; 47(5):435-40. PubMed ID: 8868136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of apomorphine fragments: dissociation of emetic and stereotypical effects.
    Burkman AM
    Neuropharmacology; 1973 Jan; 12(1):83-5. PubMed ID: 4687278
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret.
    Lau AH; Ngan MP; Rudd JA; Yew DT
    Eur J Pharmacol; 2005 Jun; 516(3):247-52. PubMed ID: 15963978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotyped behavior affected by peripheral and intracerebroventricular apomorphine administration in pigeons.
    Deviche P
    Pharmacol Biochem Behav; 1983 Mar; 18(3):323-6. PubMed ID: 6682231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 8. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
    Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
    Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening nornuciferine derivatives for apomorphine-like activity.
    Burkman AM; Cannon JG
    J Pharm Sci; 1972 May; 61(5):813-4. PubMed ID: 5035801
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 13. Supersensitivity following repeated administration of dopaminergic agonists.
    Westermann KH
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):58-63. PubMed ID: 6889805
    [No Abstract]   [Full Text] [Related]  

  • 14. 3-Aminotetrahydrocarbazoles as a new series of central nervous system agents.
    Mooradian A; Dupont PE; Hlavec AG; Aceto MD; Pearl J
    J Med Chem; 1977 Apr; 20(4):487-92. PubMed ID: 403284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-naphthoxyacetic acid-elicited retching involves dopaminergic inhibition in mice.
    Furukawa T; Yamada K
    Pharmacol Biochem Behav; 1980 May; 12(5):735-8. PubMed ID: 7393967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of prostaglandins on climbing behavior induced by apomorphine in mice.
    Brus R; Kruk Z; Wesołowska M; Stanosek B
    Pol J Pharmacol Pharm; 1982; 34(1-3):147-52. PubMed ID: 7167415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of sensitivity to ambulation-increasing effect of apomorphine induced by repeated administration in mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1984 Sep; 4(2):181-90. PubMed ID: 6543079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.